Cancer drug venture company
$Solasia Pharma KK (4597.JP)$ A small increase in purchases at the new NISA. The deficit is shrinking, so is it huge if it hits? I'm also worried that it's in the high income rankings every time
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
ヘレンカトリーナ : It's a hit.
It will go up. I want to look forward to it
こてちゅ OP ヘレンカトリーナ : The average acquisition is 49.2 yen. Speaking of greed, I'd like them to go 3 digits